Cargando...
Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma
In recent years, the incidence of liver cancer has increased and is currently the sixth most common tumor and the second leading cause of cancer-associated mortality worldwide. Most cases of liver cancer are hepatocellular carcinoma (HCC). Surgery, including liver transplantation or resection, and r...
Gardado en:
| Publicado en: | Oncol Lett |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7412709/ https://ncbi.nlm.nih.gov/pubmed/32802167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11909 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|